Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Veber

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Journal of Combinatorial Chemistry|April 4, 2000
Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and LD S Yamashita, X Dong, H J Oh, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Biopolymers|August 1, 1993
The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonistM J Bogusky, A M Naylor, M E Mertzman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitorsS K Thompson, S M Halbert, R L DesJarlais, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1978
Conformationally restricted bicyclic analogs of somatostatinD F Veber, F W Holly, W J Paleveda, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin KK J Duffy, L H Ridgers, R L DesJarlais, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
American Journal of Public Health|March 1, 1996
Separation between HIV-positive women and their children: the French prospective study, 1986 through 1993S Blanche, M J Mayaux, F Veber, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Journal of Combinatorial Chemistry|April 4, 2000
Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and LD S Yamashita, X Dong, H J Oh, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Biopolymers|August 1, 1993
The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonistM J Bogusky, A M Naylor, M E Mertzman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitorsS K Thompson, S M Halbert, R L DesJarlais, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1978
Conformationally restricted bicyclic analogs of somatostatinD F Veber, F W Holly, W J Paleveda, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin KK J Duffy, L H Ridgers, R L DesJarlais, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
American Journal of Public Health|March 1, 1996
Separation between HIV-positive women and their children: the French prospective study, 1986 through 1993S Blanche, M J Mayaux, F Veber, et al.
Pageof 10